SULLIVAN LOUIS W bought UTHR
July 24, 2025 · Form 4 insider transaction
SULLIVAN LOUIS W bought 650 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
650
Price
$0.00
Total value
N/A
InsiderSULLIVAN LOUIS W
RoleDirector
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateJuly 24, 2025
Filing dateJuly 28, 2025
Shares owned after650
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.; Annual non-employee director award.; Not applicable as restricted stock units do not have an expiration date.